ArticleViruses2025
Management of an Equine Herpesvirus-1 Outbreak During a Multi-Week Equestrian Event.
Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study reports on the management of an EHV-1 outbreak at a large, multi-week equestrian event with ongoing showing. Within a 48 h period, 8 horses out of a cohort of 38 horses from the same trainer displayed elevated rectal temperatures ranging from 38.4 to 39.0 °C. Initial testing using a point-of-care PCR assay detected EHV-1 in 2/8 horses, with the results being confirmed at a later time by qPCR. As a precautionary measure and because of the inability to isolate the entire at-risk population, the 38 horses were relocated to an equine facility outside the equestrian event for daily monitoring and weekly EHV-1 qPCR testing of nasal secretions. Overall, 22/38 (58%) horses tested EHV-1 qPCR-positive in nasal secretions over the monitoring period of 28 days, with only one additional horse developing fever. Once all 38 horses tested EHV-1 qPCR-negative twice, 7 days apart, 17 horses returned to the equestrian event to compete for the remaining 2 weeks of the circuit. The present study highlights the importance of isolating and testing horses with fever but also subfebrile horses, as EHV-1 can cause silent infection. The relocation of the exposed horses to an outside facility allowed close monitoring of these horses while reducing the risk of direct and indirect exposure to other show horses. The regular testing for EHV-1 through nasal secretions during the outbreak, coupled with proper biosecurity protocols, allowed the safe return of the show horses to the event. The key elements in reducing the spread of EHV-1 were the routine assessment of rectal temperature, early isolation of horses with elevated rectal temperature and on-site EHV-1 PCR testing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.